Market News (Page 46) - TendieTensor

Market News Page 46 of 158 • 3,926 articles

GlobeNewswire Inc. • Eramet

Eramet: Purchase of own shares

11/17/2025 12:00 PM • Eramet announced the purchase of 16,500 of its own shares related to bonus share allocations for employees and corporate officers, with transactions occurring between November 10-14, 2025.

ERMAY - Share buyback is a routine financial activity indicating stable corporate management, with no significant positive or negative implications. The purchase is specifically for employee bonus share allocations, suggesting standard corporate governance practices.

#share buyback #bonus shares #corporate finance

Divisadero Street Opens New $56 Million Stride Position: Is the Stock a Buy?

The Motley Fool • Josh Kohn-Lindquist

Divisadero Street Opens New $56 Million Stride Position: Is the Stock a Buy?

11/17/2025 11:32 AM • Divisadero Street Capital Management acquired a new $55.85 million position in Stride, representing 2.44% of its assets. Despite a recent significant stock drop due to platform upgrade issues, the author sees potential opportunity in the online education company trading at a low earnings multiple.

RIVN - High-risk electric vehicle manufacturer with potential partnerships and future mass-market vehicle plans, but currently unprofitable and stock significantly down from historical highs
LRN - Mixed performance with earnings beat but significant enrollment loss (10,000-15,000 new enrollments) due to platform upgrade issues. Trading at low earnings multiple suggests potential value, but near-term challenges exist.

#online education #investment #platform upgrade #enrollment #technology services

Why Is Everyone Excited About AMD Stock?

The Motley Fool • Parkev Tatevosian, Cfa

Why Is Everyone Excited About AMD Stock?

11/17/2025 11:32 AM • AMD is gaining market share in the data center industry, signing major deals with AI companies that are expected to boost sales and profits in the coming years.

AMD - The company is expanding its presence in the lucrative data center market, securing significant AI-related deals that suggest strong future growth potential

#AMD #AI #data center #market share #technology stocks

Sustainable Secondary Packaging Market Trends, Segments, Share and Companies 2025-35

GlobeNewswire Inc. • Towards Packaging

Sustainable Secondary Packaging Market Trends, Segments, Share and Companies 2025-35

11/17/2025 11:00 AM • The global sustainable secondary packaging market is projected to experience significant revenue growth by 2034, driven by increasing demand for eco-friendly packaging solutions, government regulations, and rising e-commerce needs. Asia Pacific currently leads the market, with Europe expected to see substantial expansion.

MONDY - Offers reusable, recyclable, and compostable paper-based solutions, aligning with market sustainability trends

#sustainable packaging #secondary packaging #eco-friendly #circular economy #recyclable materials

Cell Harvesting Market to Reach USD 20.08 Billion, Growing at a Strong 12.95% CAGR by 2034

GlobeNewswire Inc. • Towards Healthcare

Cell Harvesting Market to Reach USD 20.08 Billion, Growing at a Strong 12.95% CAGR by 2034

11/17/2025 11:00 AM • The global cell harvesting market is projected to grow from $5.94 billion in 2024 to $20.08 billion by 2034, with a 12.95% CAGR, driven by increasing demand for regenerative medicine, cell-based therapies, and technological advancements in cell research.

VOO - Historically strong performance with 12.8% annual returns, potential for significant long-term growth
TMO - Leading player in cell harvesting market with advanced technologies and strong market presence

#cell harvesting #regenerative medicine #stem cell research #biotechnology #cell therapy

ATYR Investors Have Opportunity to Lead aTyr Pharma, Inc. Securities Fraud Lawsuit with the Schall Law Firm

GlobeNewswire Inc. • The Schall Law Firm

ATYR Investors Have Opportunity to Lead aTyr Pharma, Inc. Securities Fraud Lawsuit with the Schall Law Firm

11/17/2025 11:00 AM • The Schall Law Firm is pursuing a class action lawsuit against aTyr Pharma for allegedly making false and misleading statements about its Phase 3 trial of Efzofitimod, potentially concealing the drug's true capabilities.

TSLA - Part of Magnificent Seven with significant market representation
ATYR - The company is accused of making false statements about its drug trial, potentially misleading investors about Efzofitimod's capabilities, which could result in financial damages and legal consequences

#securities fraud #class action lawsuit #Efzofitimod #Phase 3 trial

The Next Wave Of AI Winners? Investors Shift Focus Beyond Nvidia

Benzinga • Piero Cingari

The Next Wave Of AI Winners? Investors Shift Focus Beyond Nvidia

11/17/2025 10:47 AM • Investors are shifting focus from AI infrastructure builders to companies using AI for productivity gains, with Goldman Sachs identifying potential beneficiaries across finance, consulting, software, and HR services sectors.

FFAIW - Positive business developments including strategic advisor appointment, increased B2B preorders, and growing investor interest from Vanguard
BAC - Identified as potential AI productivity beneficiary in banking sector with back-office automation potential

#AI #productivity #investment #earnings #automation

DoubleDown Interactive to Donate $10,000 to Meals on Wheels America®

GlobeNewswire Inc. • Doubledown Interactive Co., Ltd.

DoubleDown Interactive to Donate $10,000 to Meals on Wheels America®

11/17/2025 10:00 AM • DoubleDown Interactive announced a $10,000 donation to Meals on Wheels America to support senior hunger and isolation, with a play-to-enter giveaway event on November 20, 2025 to engage players in the charitable initiative.

AAPL - Underperformed market, up 77% in three years, perceived as lacking in AI development
DDI - Company demonstrates corporate social responsibility by donating to a charitable cause and raising awareness about senior hunger

#donation #charity #seniors #social gaming #community support

Gene Therapies for Cancer Treatment Market Projects USD 238.77 Billion at 39.94% CAGR by 2034

GlobeNewswire Inc. • Towards Healthcare

Gene Therapies for Cancer Treatment Market Projects USD 238.77 Billion at 39.94% CAGR by 2034

11/17/2025 10:00 AM • The global gene therapies for cancer treatment market is expected to grow from $8.28 billion in 2024 to $238.77 billion by 2034, with a 39.94% CAGR. North America currently dominates the market, with CAR-T cell therapy leading market share and significant innovations driving growth.

MSFT - Part of top-performing Magnificent Seven stocks with strong market presence
LEGN - Mentioned as a key player in an emerging and rapidly growing gene therapy market for cancer treatment

#gene therapy #cancer treatment #CAR-T cell therapy #market growth #oncology

Holiday Retail Sales to Hit $1 Trillion: Which Giant Will Win Black Friday 2025?

Investing.com • Nathan Reiff

Holiday Retail Sales to Hit $1 Trillion: Which Giant Will Win Black Friday 2025?

11/17/2025 09:49 AM • The National Retail Federation predicts over $1 trillion in U.S. retail sales for the 2025 winter holidays, with Amazon, Walmart, and Target positioned to benefit from increased holiday spending despite economic challenges.

AMZN - Part of top-performing Magnificent Seven stocks with significant market representation
AMZN - Strong e-commerce presence, lowest online prices, extensive product variety, successful Black Friday sales, and international market reach

#Black Friday #holiday sales #retail #e-commerce #consumer spending

Nu Holdings Stock Presses Higher—Breakout on Deck?

Investing.com • Chris Markoch

Nu Holdings Stock Presses Higher—Breakout on Deck?

11/17/2025 09:44 AM • Nu Holdings reported strong Q3 earnings with 54% higher EPS, 41% revenue growth, and 127 million active customers. The digital bank showed robust financial performance with high customer engagement and potential for stock price breakout.

META - Part of Magnificent Seven with significant market presence but no specific performance highlights
NU - Demonstrated strong financial metrics including 54% EPS growth, 41% revenue increase, 17% customer base expansion, 83% customer activity rate, and record 31% return on equity

#fintech #digital banking #earnings report #financial services #AI-first approach

S&P 500 Forward Earnings Defy Typical Drift With Persistent Upgrades

Investing.com • Brian Gilmartin

S&P 500 Forward Earnings Defy Typical Drift With Persistent Upgrades

11/17/2025 09:38 AM • The S&P 500 forward earnings estimates are showing unexpected positive momentum, with analysts continuing to upgrade earnings projections for 2025-2027, contrary to typical downward estimate drift. Large-cap tech and AI-related sectors remain strong, though potential market challenges may emerge in 2026.

GOOG - Part of Magnificent Seven with significant market representation
GOOG - Part of large-cap tech and communication services sector with continued AI momentum

#S&P 500 #earnings estimates #AI #forward guidance #market outlook

Quantum Computing (QUBT) Stock Surges On Q3 Earnings, Company To Unveil Neurawave Computer This Week

Benzinga • Adam Eckert

Quantum Computing (QUBT) Stock Surges On Q3 Earnings, Company To Unveil Neurawave Computer This Week

11/17/2025 09:30 AM • Quantum Computing Inc reported strong Q3 earnings, beating analyst estimates with 280% year-over-year revenue growth and plans to unveil its Neurawave photonics-based reservoir computing system at SuperCompute25.

GOOGL - Part of Magnificent Seven with significant market representation
QUBT - Strong Q3 financial performance with revenue beating estimates, significant cash reserves, strategic technology development, and plans to demonstrate new computing system

#quantum computing #earnings #Neurawave #Dirac-3 #photonics

Leverage Shares by Themes expands its single stock Leveraged ETF lineup with NU, NET, OKTA, TER, NEM, CMG, ABNB, SPOT and SBUX

GlobeNewswire Inc. • Paul Marino

Leverage Shares by Themes expands its single stock Leveraged ETF lineup with NU, NET, OKTA, TER, NEM, CMG, ABNB, SPOT and SBUX

11/17/2025 09:00 AM • Leverage Shares by Themes introduced nine new single stock leveraged ETFs targeting 200% daily exposure to companies across various sectors, expanding their total leveraged ETF count to 43.

KO - Over 60 years of dividend increases, industry-leading brand, global distribution, fair current valuation, and 3% dividend yield
NET - Included in AI infrastructure investment theme with growth potential

#ETF #leveraged investment #single stock #market exposure

Varonis Recognized as a Finalist for the 2025 Microsoft Partner of the Year Award in the Marketplace Category

GlobeNewswire Inc. • Varonis Systems, Inc.

Varonis Recognized as a Finalist for the 2025 Microsoft Partner of the Year Award in the Marketplace Category

11/17/2025 09:00 AM • Varonis Systems has been named a finalist in the Marketplace Category of the 2025 Microsoft Partner of the Year Awards, recognizing its innovative data security solutions built on Microsoft technology.

VRNS - Recognized as a finalist in prestigious Microsoft Partner Awards, highlighting successful collaboration and technological innovation

#data security #Microsoft partnership #cloud innovation #AI automation

Corrugated Boxes for Transit Packaging Market Size, Trends & Trade Analysis 2025-2035

GlobeNewswire Inc. • Towards Packaging

Corrugated Boxes for Transit Packaging Market Size, Trends & Trade Analysis 2025-2035

11/17/2025 09:00 AM • The global corrugated boxes for transit packaging market is projected to grow from $345.35 billion in 2026 to $511.79 billion by 2034, with a 5.04% CAGR. Asia Pacific leads the market, driven by e-commerce, manufacturing growth, and sustainability trends.

WMT - Largest US retailer, extensive store network, over five decades of dividend increases, adaptable to economic conditions
IP - Offers wide variety of fiber-based corrugated packaging products for shipping and e-commerce needs

#corrugated boxes #transit packaging #e-commerce #sustainability #packaging market

ORAMED PHARMACEUTICALS INC. DECLARES DIVIDEND DISTRIBUTION OF COMMON STOCK PURCHASE RIGHTS

Benzinga • Prnewswire

ORAMED PHARMACEUTICALS INC. DECLARES DIVIDEND DISTRIBUTION OF COMMON STOCK PURCHASE RIGHTS

11/17/2025 08:50 AM • Oramed Pharmaceuticals announced a Rights Plan to protect against hostile takeovers, distributing one common stock purchase right per outstanding share, with rights becoming exercisable if a person/group acquires 15% or more of outstanding stock.

O - 30-year dividend growth history, largest net lease REIT, diversified market exposure, and high 5.5% dividend yield
ORMP - The company is implementing a defensive strategy to protect shareholders by establishing a rights plan that ensures fair treatment in potential acquisition scenarios, without indicating immediate positive or negative business performance

#rights plan #dividend #stock purchase #takeover defense

LifeMD® to Offer Market-Leading Pricing for GLP-1 Medications Wegovy® and Ozempic® in Continued Collaboration with Novo Nordisk

GlobeNewswire Inc. • Lifemd, Inc.

LifeMD® to Offer Market-Leading Pricing for GLP-1 Medications Wegovy® and Ozempic® in Continued Collaboration with Novo Nordisk

11/17/2025 08:00 AM • LifeMD announced lower cash-pay pricing for Wegovy and Ozempic medications at $199 per month, supporting patients paying out of pocket through its Weight Management Program in collaboration with Novo Nordisk.

SHW - Industry-leading paint and coatings company, 46-year dividend growth, technology-resistant business model
LFMD - Expanding affordable medication access, strengthening pharmaceutical partnerships, and positioning itself strategically in the weight management healthcare market

#GLP-1 #weight management #virtual healthcare #medication pricing

FDA Accepts Supplemental New Drug Application for Arcutis’ ZORYVE® (roflumilast) Cream 0.3% for the Treatment of Plaque Psoriasis in Children Ages 2 to 5

GlobeNewswire Inc. • Arcutis Biotherapeutics, Inc.

FDA Accepts Supplemental New Drug Application for Arcutis’ ZORYVE® (roflumilast) Cream 0.3% for the Treatment of Plaque Psoriasis in Children Ages 2 to 5

11/17/2025 08:00 AM • Arcutis Biotherapeutics has submitted a supplemental New Drug Application to the FDA for ZORYVE cream 0.3%, seeking approval to treat plaque psoriasis in children ages 2 to 5. If approved by the June 29, 2026 target date, it would be the first topical PDE4 inhibitor for this age group.

ADP - Trusted enterprise HR solutions, 50-year dividend growth history, resilient business model in human resources management
ARQT - Company is expanding treatment options for children, demonstrating innovation in dermatological care and potential market expansion

#FDA #psoriasis #pediatric treatment #topical medication #PDE4 inhibitor

Algorhythm Holdings to Announce its Financial Results for the Third Quarter 2025

GlobeNewswire Inc. • Brendan Hopkins

Algorhythm Holdings to Announce its Financial Results for the Third Quarter 2025

11/17/2025 08:00 AM • Algorhythm Holdings will release its Q3 2025 earnings on November 19, 2025, with a conference call to discuss financial results and provide a business update.

MCD - Global franchise model, 49-year dividend growth streak, steady revenue from royalties and global expansion potential
RIME - Standard earnings release with no explicit positive or negative financial indicators, routine announcement of quarterly results

#earnings #AI technology #logistics #conference call #Q3 2025

Calidi Biotherapeutics Announces Exclusive Live Investor Webinar and Q&A Session on November 19, 2025

GlobeNewswire Inc. • Dave Gentry

Calidi Biotherapeutics Announces Exclusive Live Investor Webinar and Q&A Session on November 19, 2025

11/17/2025 08:00 AM • Calidi Biotherapeutics is hosting an investor webinar to discuss its RedTail platform, an engineered viral therapy designed to deliver genetic medicines to tumor sites. The company aims to advance its technology towards IND filing by end of 2026, targeting oncology markets projected to exceed $560 billion by 2033.

CLDI - Company is showcasing promising preclinical data, advancing towards IND filing, has a strengthened balance sheet, and is targeting a large potential market in oncology

#biotechnology #genetic medicine #oncology #immunotherapy #viral therapy

Gabelli Launches New Exchange-Traded Fund: Gabelli High Income ETF (GBHI)

GlobeNewswire Inc. • Wayne Plewniak

Gabelli Launches New Exchange-Traded Fund: Gabelli High Income ETF (GBHI)

11/17/2025 08:00 AM • Gabelli Funds launched the Gabelli High Income ETF (GBHI), an actively managed ETF focusing on high-yield corporate bonds with a disciplined risk management approach, targeting attractive income opportunities in high-yield markets.

GAMI - Parent company mentioned without specific performance details

#ETF #high-yield bonds #fixed income #investment strategy

Mophie Expands Its Qi2 Lineup with Four New Wireless Charging Stands

GlobeNewswire Inc. • Ekshita Kumar

Mophie Expands Its Qi2 Lineup with Four New Wireless Charging Stands

11/17/2025 08:00 AM • Mophie launched four new Qi2 wireless charging stands for iPhone, Apple Watch, and AirPods, offering fast charging up to 15W with magnetic alignment and space-saving designs, ranging from $44.95 to $99.95.

AAPL - Mentioned as device compatibility partner with no direct company action

#wireless charging #Qi2 #iPhone #Apple Watch #AirPods #MagSafe

Madrigal Pharmaceuticals Announces Participation at Three Upcoming Investor Conferences

GlobeNewswire Inc. • Madrigal Pharmaceuticals

Madrigal Pharmaceuticals Announces Participation at Three Upcoming Investor Conferences

11/17/2025 08:00 AM • Madrigal Pharmaceuticals will participate in three upcoming healthcare investor conferences in November and December 2025, presenting live webcasts about their MASH treatment Rezdiffra.

MDGL - Company is actively presenting at multiple investor conferences, showcasing ongoing research and development of Rezdiffra for MASH treatment, indicating growth and investor engagement

#investor conferences #healthcare #Rezdiffra #MASH #pharmaceutical presentation

HomeTrust Bank Recognized Nationally with Three Workplace Awards, Advances to Top 100 Most Loved Workplace®

GlobeNewswire Inc. • Hometrust Bancshares, Inc.

HomeTrust Bank Recognized Nationally with Three Workplace Awards, Advances to Top 100 Most Loved Workplace®

11/17/2025 08:00 AM • HomeTrust Bank received three national workplace awards in 2025, including being named one of America's Top 100 Most Loved Workplaces, Best Bank to Work For, and America's Best Workplaces, highlighting its strong employee culture and engagement.

HTB - Company received multiple prestigious workplace awards, demonstrating strong employee satisfaction, positive corporate culture, and recognition for creating an empowering work environment

#workplace awards #employee engagement #corporate culture #banking #recognition